- $39.66m
- -$0.37m
- $20.60m
Annual balance sheet for Scynexis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 104 | 73.5 | 74.4 | 59.3 | 40 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.861 | 2.1 | 2.46 | 0.753 | 0 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 109 | 79.1 | 102 | 72.2 | 40.4 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.91 | 2.59 | 2.36 | 2.09 | 1.76 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 120 | 87.8 | 128 | 90.6 | 59 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 13.6 | 17.6 | 16.3 | 24.1 | 5.73 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 78.6 | 84.6 | 55.5 | 35.6 | 9.65 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 41.3 | 3.23 | 73 | 55.1 | 49.4 |
| Total Liabilities & Shareholders' Equity | 120 | 87.8 | 128 | 90.6 | 59 |
| Total Common Shares Outstanding |